NBY

NOVABAY PHARMA
AMEX

Real-time Quotes | Nasdaq Last Sale

0.8600
+0.2603
+43.41%
After Hours: 0.8900 +0.03 +3.49% 16:22 04/01 EDT
OPEN
0.5600
PREV CLOSE
0.5997
HIGH
0.9988
LOW
0.5382
VOLUME
16.91M
TURNOVER
--
52 WEEK HIGH
4.040
52 WEEK LOW
0.2290
MARKET CAP
24.09M
P/E (TTM)
-1.8463
1D
5D
1M
3M
1Y
5Y

Analyst Rating

Based on 2 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target

The average NBY stock price target is 1.500 with a high estimate of 1.500 and a low estimate of 1.500.

EPS

NBY News

More
  • NovaBay EPS misses by $0.06, misses on revenue
  • seekingalpha · 5d ago
  • NovaBay Pharmaceuticals, Inc. (NBY) CEO Justin Hall on Q4 2019 Results - Earnings Call Transcript
  • Seeking Alpha - Transcript · 5d ago
  • NovaBay Pharmaceuticals Reports 2019 Fourth Quarter and Full Year Financial Results
  • Business Wire · 5d ago
  • NovaBay Pharmaceuticals, Inc. to Host Earnings Call
  • ACCESSWIRE · 6d ago

Industry

Biotechnology & Medical Research
-4.34%
Pharmaceuticals & Medical Research
-2.95%

Hot Stocks

Symbol
Price
%Change

About NBY

NovaBay Pharmaceuticals, Inc., formerly NovaCal Pharmaceuticals, Inc., is a biopharmaceutical company, which develops products for the eye care market. The Company focuses on commercializing prescription Avenova for managing hygiene of the eyelids and lashes in the United States. Avenova is an eye care product formulated with a form of hypochlorous acid called Neutrox. Its Avenova with Neutrox removes debris from the skin on the eyelids and lashes without burning or stinging. It develops additional products containing Neutrox, including its NeutroPhase Skin and Wound Cleanser for wound care and CelleRx for the dermatology market. Its Aganocide compounds, led by auriclosene (NVC-422), are synthetic molecules with activity against bacteria, viruses and fungi. The Company's dermatology product includes CelleRx, a cleansing solution for post laser resurfacing, chemical peels and other cosmetic surgery procedures. Its wound care business includes the business of NeutroPhase product.
More

Webull offers kinds of NovaBay Pharmaceuticals, Inc. stock information, including AMEX:NBY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, NBY stock news, and many more online research tools to help you make informed decisions.